Methodist Hospital Research Institute, Center for Diabetes Research, Weill Cornell Medical College, The Methodist Hospital, Houston, Texas 77030.
Methodist Hospital Research Institute, Center for Diabetes Research, Weill Cornell Medical College, The Methodist Hospital, Houston, Texas 77030.
J Biol Chem. 2011 Sep 2;286(35):30723-30731. doi: 10.1074/jbc.M111.251926. Epub 2011 Jun 30.
Peroxisome proliferator-activated receptor γ (PPARγ) activation induces adipogenesis and also enhances lipogenesis, mitochondrial activity, and insulin sensitivity in adipocytes. Whereas some studies implicate PPARγ coactivator 1α (PGC-1α) in the mitochondrial effect, the mechanisms involved in PPARγ regulation of adipocyte mitochondrial function are not resolved. PPARγ-activating ligands (thiazolidinediones (TZDs)) are important insulin sensitizers and were recently shown to indirectly induce PGC-1β transcription in osteoclasts. Here, we asked whether similar effects occur in adipocytes and show that TZDs also strongly induce PGC-1β in cultured 3T3-L1 cells. This effect, however, differs from the indirect effect proposed for bone and is rapid and direct and involves PPARγ interactions with an intronic PPARγ response element cluster in the PGC-1β locus. TZD treatment of cultured adipocytes results in up-regulation of mitochondrial marker genes, and increased mitochondrial activity and use of short interfering RNA confirms that these effects require PGC-1β. PGC-1β did not participate in PPARγ effects on adipogenesis or lipogenesis, and PGC-1β knockdown did not alter insulin-responsive glucose uptake into 3T3-L1 cells. Similar effects on PGC-1β and mitochondrial gene expression are seen in vivo; fractionation of obese mouse adipose tissue reveals that PPARγ and PGC-1β, but not PGC-1α, are coordinately up-regulated in adipocytes relative to preadipocytes and that TZD treatment induces PGC-1β and mitochondrial marker genes in adipose tissue of obese mice. We propose that PPARγ directly induces PGC-1β expression in adipocytes and that this effect regulates adipocyte mitochondrial activity.
过氧化物酶体增殖物激活受体 γ(PPARγ)的激活可诱导脂肪生成,还可增强脂肪细胞中的脂肪生成、线粒体活性和胰岛素敏感性。虽然一些研究表明过氧化物酶体增殖物激活受体 γ 共激活剂 1α(PGC-1α)参与了线粒体效应,但 PPARγ 调节脂肪细胞线粒体功能的机制尚未解决。PPARγ 激活配体(噻唑烷二酮(TZD))是重要的胰岛素增敏剂,最近有研究表明其可间接诱导破骨细胞中 PGC-1β 的转录。在这里,我们询问是否在脂肪细胞中也存在类似的作用,并表明 TZD 也可强烈诱导培养的 3T3-L1 细胞中 PGC-1β 的表达。然而,这种作用与骨中的间接作用不同,是快速且直接的,涉及 PPARγ 与 PGC-1β 基因座中内含子 PPARγ 反应元件簇的相互作用。TZD 处理培养的脂肪细胞可上调线粒体标记基因,并增加线粒体活性和使用短干扰 RNA 证实这些作用需要 PGC-1β。PGC-1β 不参与 PPARγ 对脂肪生成或脂肪生成的影响,PGC-1β 敲低不会改变 3T3-L1 细胞中胰岛素响应的葡萄糖摄取。在体内也观察到对 PGC-1β 和线粒体基因表达的类似影响;肥胖小鼠脂肪组织的分级分离显示,与前脂肪细胞相比,PPARγ 和 PGC-1β 而不是 PGC-1α 在脂肪细胞中协同上调,TZD 处理可诱导肥胖小鼠脂肪组织中 PGC-1β 和线粒体标记基因的表达。我们提出,PPARγ 可直接诱导脂肪细胞中 PGC-1β 的表达,而这种作用可调节脂肪细胞中线粒体的活性。